Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Janux Therapeutics, Inc. (JANX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
13 Nov 2023
Avalon Ventures XI, L.P.
10% Owner
Janux Therapeutics, Inc.
(JANX)
849,854
+100%
849,854
$5.87
$4,988,643.00
BUY
13 Nov 2023
Lichter Jay
Director, 10% Owner
Janux Therapeutics, Inc.
(JANX)
849,854
+100%
849,854
$5.87
$4,988,643.00
BUY
13 Nov 2023
Reardon Tighe
Acting Chief Financial Officer, Officer, 10% Owner
Janux Therapeutics, Inc.
(JANX)
849,854
+100%
849,854
$5.87
$4,988,643.00
SELL
29 Dec 2021
ORBIMED ADVISORS LLC
Director
Janux Therapeutics, Inc.
(JANX)
2,258,566
-1%
40,400
$20.30
$820,120.00
SELL
29 Dec 2021
Thompson Peter A.
Director
Janux Therapeutics, Inc.
(JANX)
2,258,566
-1%
40,400
$20.30
$820,120.00
SELL
21 Dec 2021
ORBIMED ADVISORS LLC
Director
Janux Therapeutics, Inc.
(JANX)
2,295,266
-4%
119,400
$19.00
$2,268,600.00
SELL
21 Dec 2021
Thompson Peter A.
Director
Janux Therapeutics, Inc.
(JANX)
2,295,266
-4%
119,400
$19.00
$2,268,600.00
SELL
16 Dec 2021
ORBIMED ADVISORS LLC
Director
Janux Therapeutics, Inc.
(JANX)
2,403,566
-14%
393,300
$19.07
$7,500,231.00
SELL
16 Dec 2021
Thompson Peter A.
Director
Janux Therapeutics, Inc.
(JANX)
2,403,566
-14%
393,300
$19.07
$7,500,231.00
BUY
15 Jun 2021
Bregua Corp
10% Owner
Janux Therapeutics, Inc.
(JANX)
3,749,250
+1%
58,823
$17.00
$999,991.00
BUY
15 Jun 2021
Lichter Jay
Director, 10% Owner
Janux Therapeutics, Inc.
(JANX)
4,479,492
+16%
629,411
$17.00
$10,699,987.00
BUY
15 Jun 2021
RA CAPITAL MANAGEMENT, L.P.
Director, 10% Owner
Janux Therapeutics, Inc.
(JANX)
7,622,238
+62%
2,941,176
$17.00
$49,999,990.00
BUY
15 Jun 2021
ORBIMED ADVISORS LLC
Director
Janux Therapeutics, Inc.
(JANX)
2,760,366
+34%
705,853
$17.00
$11,999,501.00
BUY
15 Jun 2021
Avalon Ventures XI, L.P.
10% Owner
Janux Therapeutics, Inc.
(JANX)
4,479,492
+16%
629,411
$17.00
$10,699,987.00
BUY
15 Jun 2021
Reardon Tighe
Acting Chief Financial Officer, Officer, 10% Owner
Janux Therapeutics, Inc.
(JANX)
4,479,492
+16%
629,411
$17.00
$10,699,987.00
BUY
15 Jun 2021
Thompson Peter A.
Director
Janux Therapeutics, Inc.
(JANX)
2,760,366
+34%
705,853
$17.00
$11,999,501.00
Home